BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33008481)

  • 1. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors.
    Fujiwara S; Kawamoto T; Kawakami Y; Koterazawa Y; Hara H; Takemori T; Kitayama K; Yahiro S; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Koyanagi-Aoi M; Aoi T; Kuroda R; Akisue T
    Stem Cell Res Ther; 2020 Oct; 11(1):429. PubMed ID: 33008481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cancer stem cell properties in colon cancer cells by defined factors.
    Oshima N; Yamada Y; Nagayama S; Kawada K; Hasegawa S; Okabe H; Sakai Y; Aoi T
    PLoS One; 2014; 9(7):e101735. PubMed ID: 25006808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
    Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
    Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
    Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective autophagy leads to the suppression of stem-like features of CD271
    Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
    J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma.
    Maurizi G; Verma N; Gadi A; Mansukhani A; Basilico C
    Oncogene; 2018 Aug; 37(33):4626-4632. PubMed ID: 29743593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
    Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
    Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of stem cell attributes in human osteosarcoma cell lines.
    Wang L; Park P; Lin CY
    Cancer Biol Ther; 2009 Mar; 8(6):543-52. PubMed ID: 19242128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
    Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
    J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
    Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
    Zhao D; Wang S; Chu X; Han D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
    Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
    Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
    Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
    Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
    La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
    J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.